VBIV

VBI Vaccines Announces Initial Positive Phase 1 Data for Its eVLP Vaccine Candidate Against COVID-19

VBI Vaccines (VBIV) is in Overbought Territory: What's Next?

VBI Vaccines (VBIV) Up on Glioblastoma Drug Fast Track Status

VBI Vaccines' Brain Cancer Immunotherapy Gets FDA Fast Track Review; Announces Updated Tumor Response, Overall Survival Data

VBI Vaccines Secures $12M In Second Tranche of Debt Financing With K2 HealthVentures

VBI Vaccines' Three-Antigen HBV Vaccine Candidate Trial Data Published In Lancet Infectious Diseases